SCHEMBL1695173

SCHEMBL1695173

COCC(N)(Cc1ccccc1)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.49
SLC6A2 P23975 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
ARG1 P05089 1/20 0.43
ARG2 P78540 1/20 0.43
TSHR P16473 1/20 0.38
RECQL P46063 2/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
EPHX1 P07099 1/20 0.38
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPRA P18433 1/20 0.38
PTPRB P23467 1/20 0.38
ALDH1A1 P00352 2/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16447680 0.88 SMN1; SMN2 (0.55) SMN1; SMN2HIF1ASLC6A2TAAR1ARG1
SCHEMBL8843838 0.84 SMN1; SMN2 (0.61) SMN1; SMN2HIF1ASLC6A2TAAR1ARG1
Hydrochloric Acid SCHEMBL8556297 0.82 SMN1; SMN2 (0.59) SMN1; SMN2HIF1ASLC6A2TAAR1ARG1
SCHEMBL5272375 0.81 HIF1A (0.53) SMN1; SMN2HIF1ASLC6A2TAAR1ARG1
SCHEMBL5272379 0.81 HIF1A (0.53) SMN1; SMN2HIF1ASLC6A2TAAR1ARG1
SCHEMBL8578234 0.79 SMN1; SMN2 (0.43) SMN1; SMN2HIF1ASLC6A2TAAR1TSHR
SCHEMBL7514054 0.77 SMN1; SMN2 (0.53) SMN1; SMN2HIF1ASLC6A2TAAR1ARG1
SCHEMBL410219 0.77 SMN1; SMN2 (0.49) SMN1; SMN2HIF1ASLC6A2TAAR1ARG1
SCHEMBL410218 0.77 SMN1; SMN2 (0.49) SMN1; SMN2HIF1ASLC6A2TAAR1ARG1
SCHEMBL28095334 0.75 ARG1 (0.52) SMN1; SMN2HIF1ASLC6A2TAAR1ARG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013072933-A2 PROCESS FOR PREPARATION OF 2-ACETAMIDO-N-BENZYL-3-METHOXYPROPIONAMIDE GLENMARK GENERICS LIMITED (IN) 2013-05-23 WO claimed
EP-2534127-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN Laboratories Limited (IN) 2012-12-19 EP claimed
WO-2011099033-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN LABORATORIES LIMITED (IN) 2011-08-18 WO claimed
EP-2914574-A2 NEW PROCESS Cambrex Karlskoga Ab (SE) 2015-09-09 EP disclosed
WO-2014068333-A2 NEW PROCESS CAMBREX KARLSKOGA AB (SE) 2014-05-08 WO disclosed
WO-2013072933-A2 PROCESS FOR PREPARATION OF 2-ACETAMIDO-N-BENZYL-3-METHOXYPROPIONAMIDE GLENMARK GENERICS LIMITED (IN) 2013-05-23 WO disclosed
EP-2582833-A1 ENZYMATIC RESOLUTION OF RACEMIC (2R,S)-2-(ACETYLAMINO)-3-METHOXY-N-(PHENYLMETHYL)PROPANAMIDE Medichem, S.A. (ES) 2013-04-24 EP disclosed
EP-2534127-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN Laboratories Limited (IN) 2012-12-19 EP disclosed
WO-2011158194-A1 ENZYMATIC RESOLUTION OF RACEMIC (2R,S)-2-(ACETYLAMINO)-3-METHOXY-N-(PHENYLMETHYL)PROPANAMIDE MEDICHEM, S.A. (ES) 2011-12-22 WO disclosed
WO-2011099033-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN LABORATORIES LIMITED (IN) 2011-08-18 WO disclosed
WO-2000000463-A1 ANTICONVULSANT ENANTIOMERIC AMINO ACID DERIVATIVES RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 2000-01-06 WO disclosed